Purchase Order 36C24723P0403

Award Date 2/1/23
Potential Completion Date 1/31/28
Potential Value $770K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Charleston, SC 29401, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a $77,295.91 firm fixed price delivery order contract to Veracyte, Inc., a for-profit organization, to provide the AFIRMA Thyroid Genomic Classifier (GEC) test. This test analyzes gene expression patterns in thyroid biopsy samples to aid in diagnosis and treatment planning. The contract was issued without a set-aside and has a period of performance through November 4, 2022. Veracyte has also been awarded an Indefinite Delivery Indefinite...
The U.S. Department of Veterans Affairs (VA), through the Veterans Integrated Service Network 8, awarded a firm-fixed price Delivery Order contract to Veracyte, Inc. to provide the AFIRMA Genomic Sequencing Classifier. This service supports cancer detection efforts at VA medical facilities by analyzing gene expression patterns in biopsy samples to determine malignancy risk, aiding diagnosis and treatment decisions. The contract has a ceiling value of $96,960.00 and a period of performance...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The $136,469.48 contract provides Thyroid Fine Needle Aspiration (AFIRMA) genetic classifier testing services to support cancer detection efforts at the G.V. (Sonny) Montgomery VA Medical Center in Jackson, MS. This order was issued under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract between Veracyte and the VA's...
This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services, to conduct referral laboratory testing for thyroid genomic expression classifier (GEC) testing. The $202,552.00 contract has a period of performance through September 30, 2024. Veracyte has provided similar genomic testing services to support cancer detection and diagnosis for...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 16 (VISN 16), part of the U.S. Department of Veterans Affairs, to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for thyroid testing services, with a ceiling value of $165,200.00 and a period of performance through April 30, 2026. Veracyte has provided similar laboratory testing services to the Department of Defense and Veterans Affairs in the past, using...
This firm fixed-price purchase order was awarded by the Veterans Health Administration's Veterans Integrated Service Network 17 (VISN 17) to Veracyte, Inc., a for-profit corporation that provides genomic testing services. The $512,000.00 contract will support cancer detection and diagnosis efforts for VISN 17 facilities through August 2027. Veracyte will provide genomic classifier laboratory testing to analyze gene expression patterns in biopsy samples, aiding in the diagnosis and treatment of...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 to Veracyte, Inc., a for-profit corporate entity specializing in advanced genomic testing services for medical diagnostics. The contract, valued at $450,516.00, is for GENOMIC TESTING services and has an ultimate completion date of May 31, 2029. Veracyte, Inc. will provide precision molecular diagnostic laboratory services, including specialized...
This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command to Veracyte, Inc., a for-profit organization that provides genomic testing services. The contract, valued at $96,176.63, is for the provision of supply/service in support of the agency's cancer detection and diagnosis efforts. Veracyte holds an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with the Veterans Health Administration's Veterans Integrated Service Network 23, valued at up to...
This is a $84,000.00 firm fixed-price Delivery Order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit corporate entity specializing in advanced genomic testing services for medical diagnostics. The contract provides reference laboratory services for VISN 23. This award is not set-aside for any specific business category. Veracyte holds several significant Indefinite Delivery Vehicle (IDV) contracts with the VA and...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs, to Veracyte, Inc. for molecular thyroid testing services. The contract has a total ceiling value of $484,800.00 and a period of performance through August 31, 2029. Veracyte is a for-profit organization that provides genomic testing services, including for cancer screening and diagnosis, to federal agencies. This award is part...

The Department of Veterans Affairs Network Contracting Office 7 awarded a firm fixed-price purchase order to Veracyte, Inc. for $770,000 to provide thyroid molecular genomic sequencing diagnostic services, equivalent to the Afirma Genomic Sequencing Classifier (CPT code 81546) and the Afirma Xpression Atlas (CPT code 0204U), to the Ralph H. Johnson VA Medical Center for one base year with four one-year option periods. This contract is not set aside. Veracyte, a for-profit company, has previously provided genomic testing services to the Department of Defense and Veterans Affairs to support cancer detection and diagnosis. The award is part of a larger Indefinite Delivery Indefinite Quantity contract vehicle from the Veterans Health Administration's Veterans Integrated Service Network 23, with a potential value of $600,000 through April 2028, that enables efficient access to Veracyte's commercial laboratory capabilities for supplemental diagnostic services.

Generated 11/5/24, 9:29 AM